We’ve had recent posts connecting the failure of ASR hip implants and cancer. According to a study in Finland as well as a report in the British Medical Journal (BMJ), there were strong indications of a link between lymphoma and leukemia a decade after the hip implant was implanted. The findings in the Finnish study suggested that the risk of cancer to such patients may be as much as 300% higher than that of the general population.
New information came to light indicating that DePuy was fully aware of the defects of its ASR hip implants before the FDA requested additional data on the abnormally high failure rates of its product. The hip replacement recall of the ASR hip implants came shortly after DePuy received a communication from the FDA refusing approval of the device and requesting additional information on the implant's failure.
Not me! It wasn't me!” It's a statement you expect out of a small child who is confronted over a broken vase or or other damage and the evidence overwhelmingly points to him.
New York Times Article Points Out That DePuy Knew About The Cobalt and Chromium Toxic Problems Well Before They Pulled It From The Market
The law firm of Levin, Papantonio, et al. finds it interesting that Johnson & Johnson execs began phasing out the DePuy ASR hip implant in 2009, mere weeks after the F.D.A. sent the company a request for additional safety data on the implant, according to New York Times article, “Hip Device Phaseout Followed F.D.A. Data Request.” It seems the F.D.A.
Odd times we live in. For instance, time was if the captain of a ship had crew members whose behavior resulted in unnecessary injuries or loss of property, or even simply reflected badly on the organization, the captain bore ultimate liability and usually suffered consequences – such as loss of his command.
“This isn’t the unlucky failure to spot the misdemeanours of one rogue company or the occasional unforeseen breakdown of a small number of devices. It is the inability to prevent a whole class of failing hip implant from being used in hundreds of thousands of people globally...” - Deborah Cohen, Investigations Editor for the British Medical Journal 28 February 2012
A few years ago, I began having severe knee pain – particularly during cold, damp weather. On one of those rare occasions that I was able to see a doctor, the diagnosis was - “You're getting older – get used to it.”
If this story isn't a damning indictment of the U.S. profit-driven health care “system,” it's hard to know what is.
Recently, a story in the New York Times reported that Johnson & Johnson, parent company of DePuy Orthopaedics, continued to sell its defective joint implants overseas after the devices had been pulled from the U.S. market.